Israel - English - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - film coated tablets - oclacitinib maleate 16 mg - control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Israel - English - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - film coated tablets - oclacitinib maleate 3.6 mg - control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Israel - English - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - film coated tablets - oclacitinib maleate 5.4 mg - control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - dibotermin alfa - bone morphogenetic proteins - dogs - osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - meloxicam - oxicams - dogs - alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - dirlotapide - antiobesity preparations, excl. diet products - dogs - as an aid in the management of overweight and obesity in adult dogs. to be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated west nile virus, strain vm-2 - immunologicals for equidae - horses - for the active immunisation of horses of six months of age or older against west-nile-virus disease by reducing the number of viraemic horses.

European Union - English - EMA (European Medicines Agency)

zoetis belgium - inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - immunologicals - cattle - active immunisation of cattle from three months of age for the prevention of viraemia caused by bluetongue virus, serotype 8.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibacterials for systemic use - pigs; cattle; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis sensitive to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. draxxin should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - oclacitinib maleate - agents for dermatitis, excluding corticosteroids - dogs - - treatment of pruritus associated with allergic dermatitis in dogs.- treatment of clinical manifestations of atopic dermatitis in dogs.